Majid, Sandralyn B.
HRN: 22-35-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFUROXIME 750MG (VIAL)
12/26/2022
01/02/2023
IV
750mg
Q8h
Age With Moderate Dhn
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes